Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ensysce Biosciences (ENSC) Revenue (2020 - 2025)

Historic Revenue for Ensysce Biosciences (ENSC) over the last 6 years, with Q3 2025 value amounting to $493104.0.

  • Ensysce Biosciences' Revenue fell 8557.69% to $493104.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year increase of 150.56%. This contributed to the annual value of $5.2 million for FY2024, which is 13357.92% up from last year.
  • Per Ensysce Biosciences' latest filing, its Revenue stood at $493104.0 for Q3 2025, which was down 8557.69% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Ensysce Biosciences' Revenue registered a high of $3.4 million during Q3 2024, and its lowest value of $181797.0 during Q2 2024.
  • For the 5-year period, Ensysce Biosciences' Revenue averaged around $877865.6, with its median value being $515032.0 (2023).
  • As far as peak fluctuations go, Ensysce Biosciences' Revenue skyrocketed by 68525.72% in 2024, and later crashed by 8557.69% in 2025.
  • Ensysce Biosciences' Revenue (Quarter) stood at $1.6 million in 2021, then dropped by 12.34% to $1.4 million in 2022, then crashed by 64.07% to $515032.0 in 2023, then soared by 153.12% to $1.3 million in 2024, then crashed by 62.18% to $493104.0 in 2025.
  • Its Revenue was $493104.0 in Q3 2025, compared to $1.4 million in Q2 2025 and $1.3 million in Q1 2025.